REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Paypiersa Pharma S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Paypiersa Pharma S.A. Profile Updated: April 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Paypiersa Pharma S.A. is based in Ecuador. The head office is in Guayaquil. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on August 04, 1998. 7 (2023) employees currently work for Paypiersa Pharma S.A.. In its most recent financial highlights, the company reported a net sales revenue increase of 11.33% in 2023. Over the same period, its total assets grew by 3.69%. The enterprise’s net profit margin decreased by 4.51% in 2023.

Headquarters
Luis Orrantia, San Pedro Bldg. , Floor 43
Guayaquil; Guayas;

Contact Details: Purchase the Paypiersa Pharma S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Paypiersa Pharma S.A. report to view the information.
Outstanding Shares:
Purchase the Paypiersa Pharma S.A. report to view the information.
Registered Capital:
Purchase the Paypiersa Pharma S.A. report to view the information.
Incorporation Date:
August 04, 1998
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
34%
Purchase this report to view the information.
34%
Purchase this report to view the information.
32%
Company Performance
Financial values in the chart are available after Paypiersa Pharma S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
11.33%▲
Total operating revenue
11.33%▲
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
-20.63%▼
Total assets
3.69%▲
Total equity
17.48%▲
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-4.51%▼
Return on Equity (ROE)
-22.16%▼
Debt to Equity Ratio
-0.05%▼
Quick Ratio
0.37%▲
Cash Ratio
0.16%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo